CD8A and neoplasm: Many metabolic pathways are shared between tumor cells and immune effector cells, such as CD8+ T cells, which rely on similar metabolic processes, including glycolysis and oxidative phosphorylation.[34] This overlap means that targeting tumor metabolism can inadvertently affect immune cell function, potentially impairing the antitumor immune response.